D Sainty

Summary

Affiliation: Institut Paoli-Calmettes
Country: France

Publications

  1. pmc Genome profiling of chronic myelomonocytic leukemia: frequent alterations of RAS and RUNX1 genes
    Véronique Gelsi-Boyer
    Centre de Recherche en Cancerologie de Marseille, Laboratoire d Oncologie Moleculaire, UMR891 Inserm, Institut Paoli Calmettes, Marseille, France
    BMC Cancer 8:299. 2008
  2. ncbi A new morphologic classification system for acute promyelocytic leukemia distinguishes cases with underlying PLZF/RARA gene rearrangements
    D Sainty
    Department of Biology, Institut Paoli Calmettes, Marseille, France
    Blood 96:1287-96. 2000
  3. ncbi Role of induction chemotherapy and bone marrow transplantation in adult lymphoblastic lymphoma: a report on 62 patients from a single center
    R Bouabdallah
    Department of Hematology, Institut J Paoli I Calmettes, Marseille, France
    Ann Oncol 9:619-25. 1998
  4. ncbi Detection of epithelial cells in hematopoietic organs of patients with breast cancer. Physiopathological significance and clinical consequences
    C Chabannon
    Institut Paoli Calmettes, Centre Régional de Lutte Contre le Cancer Provence Alpes Côte d Azur, Marseille, France
    Acta Haematol 105:166-71. 2001
  5. ncbi High-dose recombinant interleukin-2 and acute myeloid leukemias in relapse
    D Maraninchi
    Department of Hematology, Institut Paoli Calmettes, Marseille, France
    Blood 78:2182-7. 1991
  6. ncbi Primary plasma cell leukaemia: a report of 18 cases
    R Costello
    Departement d Hematologie, Institut Paoli Calmettes, 232 Bd de Sainte Marguerite, 13009 Marseille, France
    Leuk Res 25:103-7. 2001
  7. ncbi Askin tumor and acute myeloid leukemia in a patient with constitutional partial Y disomy
    M J Mozziconacci
    , Institut Paoli Calmettes, Marseille, France
    Cancer Genet Cytogenet 103:11-4. 1998
  8. ncbi Survey of early disapearance of BCR/ABL fusion transcript after allogeneic or autologous stem cell transplantation for chronic myelogenous leukemia
    N Vey
    Department of Hematology, Institut Paoli Calmettes and Université de la Mediterranée, Marseille, France
    Leuk Lymphoma 42:945-52. 2001
  9. ncbi Circulating blood dendritic cells from myeloid leukemia patients display quantitative and cytogenetic abnormalities as well as functional impairment
    M Mohty
    Laboratoire d'Immunologie des Tumeurs, , Marseille, France
    Blood 98:3750-6. 2001
  10. ncbi True histiocytic lymphoma following B-acute lymphoblastic leukaemia: case report with evidence for a common clonal origin in both neoplasms
    R Bouabdallah
    Department of Haematology, Cancer Centre Institut Paoli Calmettes, Universite de la Mediterranee, Marseille, France
    Br J Haematol 113:1047-50. 2001

Collaborators

Detail Information

Publications18

  1. pmc Genome profiling of chronic myelomonocytic leukemia: frequent alterations of RAS and RUNX1 genes
    Véronique Gelsi-Boyer
    Centre de Recherche en Cancerologie de Marseille, Laboratoire d Oncologie Moleculaire, UMR891 Inserm, Institut Paoli Calmettes, Marseille, France
    BMC Cancer 8:299. 2008
    ..Not much is known about the molecular biology of this disease...
  2. ncbi A new morphologic classification system for acute promyelocytic leukemia distinguishes cases with underlying PLZF/RARA gene rearrangements
    D Sainty
    Department of Biology, Institut Paoli Calmettes, Marseille, France
    Blood 96:1287-96. 2000
    ..Use of this classification system, combined with an analysis for CD56 expression, should allow early recognition of APL cases requiring tailored molecular investigations. (Blood. 2000;96:1287-1296)..
  3. ncbi Role of induction chemotherapy and bone marrow transplantation in adult lymphoblastic lymphoma: a report on 62 patients from a single center
    R Bouabdallah
    Department of Hematology, Institut J Paoli I Calmettes, Marseille, France
    Ann Oncol 9:619-25. 1998
    ..To describe the outcome of an unselected large series of patients with lymphoblastic lymphoma (LBL) treated in a single institution...
  4. ncbi Detection of epithelial cells in hematopoietic organs of patients with breast cancer. Physiopathological significance and clinical consequences
    C Chabannon
    Institut Paoli Calmettes, Centre Régional de Lutte Contre le Cancer Provence Alpes Côte d Azur, Marseille, France
    Acta Haematol 105:166-71. 2001
    ....
  5. ncbi High-dose recombinant interleukin-2 and acute myeloid leukemias in relapse
    D Maraninchi
    Department of Hematology, Institut Paoli Calmettes, Marseille, France
    Blood 78:2182-7. 1991
    ..These results showing clinical activity of high-dose recombinant IL-2 in AML invite further evaluation of this new form of immunotherapy in other clinical situations, like an adjuvant setting for selected groups of high-risk patients...
  6. ncbi Primary plasma cell leukaemia: a report of 18 cases
    R Costello
    Departement d Hematologie, Institut Paoli Calmettes, 232 Bd de Sainte Marguerite, 13009 Marseille, France
    Leuk Res 25:103-7. 2001
    ..They expressed integrins which may increase their binding to endothelial cells and thus participate in PCL physiopathology by favoring plasmocyte extramedullary spread...
  7. ncbi Askin tumor and acute myeloid leukemia in a patient with constitutional partial Y disomy
    M J Mozziconacci
    , Institut Paoli Calmettes, Marseille, France
    Cancer Genet Cytogenet 103:11-4. 1998
    ..The origin of the two neoplasias in this patient is discussed...
  8. ncbi Survey of early disapearance of BCR/ABL fusion transcript after allogeneic or autologous stem cell transplantation for chronic myelogenous leukemia
    N Vey
    Department of Hematology, Institut Paoli Calmettes and Université de la Mediterranée, Marseille, France
    Leuk Lymphoma 42:945-52. 2001
    ..This suggests that the GVL effect might be operational early during the first weeks following transplantation...
  9. ncbi Circulating blood dendritic cells from myeloid leukemia patients display quantitative and cytogenetic abnormalities as well as functional impairment
    M Mohty
    Laboratoire d'Immunologie des Tumeurs, , Marseille, France
    Blood 98:3750-6. 2001
    ..Also, leukemic PDCs were altered in their ability to secrete interferon-alpha. These data provide evidence that DC subsets in vivo may be affected by leukemogenesis and may contribute to leukemia escape from immune control...
  10. ncbi True histiocytic lymphoma following B-acute lymphoblastic leukaemia: case report with evidence for a common clonal origin in both neoplasms
    R Bouabdallah
    Department of Haematology, Cancer Centre Institut Paoli Calmettes, Universite de la Mediterranee, Marseille, France
    Br J Haematol 113:1047-50. 2001
    ..Genotypic study showed that both neoplasms contained the same immunoglobulin heavy gene rearrangement, which has not been reported previously...
  11. ncbi HLA-DR and B7-2 (CD86) monocyte expressions after major cancer surgery: profile in sepsis
    D Mokart
    Department of Anesthesia and Resuscitation, Paoli Calmettes Institute, Marseille, France
    Minerva Anestesiol 77:522-7. 2011
    ..The aim of the present study was to determine the possible role of monocyte HLA-DR and B7-2 molecules in the occurrence of postoperative sepsis after major cancer surgery...
  12. ncbi Large granular lymphocytes (LGL) following non-myeloablative allogeneic bone marrow transplantation: a case report
    M Mohty
    Laboratoire d'Immunologie des Tumeurs, Institut Paoli-Calmettes, , Marseille, France
    Bone Marrow Transplant 28:1157-60. 2001
    ..These observations suggest that LGL are a subset with the properties of effector lymphocytes which may contribute to the graft-versus-tumor effect...
  13. ncbi Occult tumor cell contamination in patients with stage II/III breast cancer receiving sequential high-dose chemotherapy
    F Viret
    Department of Medicine, Institut Paoli Calmettes, Marseille, France
    Bone Marrow Transplant 32:1059-64. 2003
    ..Three of these eight patients relapsed. This study has confirmed that contamination of apheresis products remains a rare event, which does not seem to affect clinical evolution, even when reinfused into the patient...
  14. ncbi Autologous stem cell transplantation for acute myelogenous leukemia in first complete remission: a 6-year follow-up study of 101 patients from a single institution
    N Vey
    Department of Hematology, Institut Paoli Calmettes, 232 Boulevard de Sainte Marguerite, 13273 Marseille Cedex 9, France
    Bone Marrow Transplant 33:177-82. 2004
    ..They show that use of PBSC is associated to very low mortality rate and acceptable morbidity and contributes to an improvement of autotransplant results...
  15. ncbi Features of large granular lymphocytes (LGL) expansion following allogeneic stem cell transplantation: a long-term analysis
    M Mohty
    Unité de Transplantation et de Thérapie Cellulaire UTTC, Institut Paoli Calmettes, Marseille, France
    Leukemia 16:2129-33. 2002
    ..These data suggest that LGL might be a subset of effector lymphocytes which may participate to the graft-versus-tumor effect...
  16. ncbi Cytomegalovirus-specific immune recovery following allogeneic HLA-identical sibling transplantation with reduced-intensity preparative regimen
    M Mohty
    Unite de Transplantation et de Therapie Cellulaire, Laboratoire d Immunologie des Tumeurs, Institut Paoli Calmettes, Marseille, France
    Bone Marrow Transplant 33:839-46. 2004
    ..Thus, early monitoring of CMV-specific immune recovery using sensitive new tools might prove useful for patient management after allo-SCT...
  17. ncbi Decreased RBCTs after reduced intensity conditioning allogeneic stem cell transplantation: predictive value of prior Hb level
    V Ivanov
    Unit of Transplantation and Cellular Therapy, Institut Paoli Calmettes, Universite de la Mediterranee, Marseille, France
    Transfusion 44:501-8. 2004
    ..RBCT (RBCT) requirements of stem cell transplant (SCT) recipients are often substantial and may be related to transplant type...
  18. ncbi Early administration of recombinant erythropoietin improves hemoglobin recovery after reduced intensity conditioned allogeneic stem cell transplantation
    V Ivanov
    Unit of Transplantation and Cellular Therapy, Institut Paoli Calmettes, Marseille Cedex, France
    Bone Marrow Transplant 36:901-6. 2005
    ..This pilot study suggests a potential benefit of early administration of rHuEPO after RIC allo-SCT on early erythropoietic recovery...